New pressure-to-cornea index in glaucoma created

Article

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor.

A new pressure-to-cornea index (PCI) has been created in an attempt to integrate intraocular pressure (IOP) and central corneal thickness (CCT) into a unified risk factor, according to a report published in the October issue of the British Journal of Ophthalmology.

Milko Iliev from the University of Bern, Switzerland and colleagues from Ophthalmologists Association Thun, Switzerland and Yale University School of Medicine, New Haven, USA defined PCI as the ration between untreated IOP and CCT3 in mm (ultrasound pachymetry).

PCI was then investigated in 220 normal controls, 53 subjects with normal-tension glaucoma (NTG), 76 with ocular hypertension (OHT) and 89 with primary open-angle glaucoma (POAG). The ability of PCI to discriminate between glaucoma and non-glaucoma was compared with that of three other formulae for correcting IOP for CCT. Receiver operating characteristic curves (ROC) were then built.

The mean PCI value in the control group was 92.0, 129.1 in the NTG group, 134.0 in the OHT group and 173.6 in the POAG group. PCI demonstrated a larger area under the ROC and significantly higher sensitivity at fixed 80% and 90% specificities than any of the other formulae. Optimum PCI cut-off value was 133.8.

The authors believe that PCI may reflect individual susceptibility to a given IOP level and, therefore, represents a glaucoma risk factor.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.